SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human clinical trial. A Phase… Continue reading D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
Tag: Strategy
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that through its wholly-owned subsidiary, it has exercised its warrant to acquire the common stock in Spruce Biosciences, Inc. (Nasdaq: SPRB) (“Spruce”). Following… Continue reading Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation
In the letter, Elliott outlined its opposition to the revised tender offer by Toyota Fudosan Co., Ltd. at ¥18,800 per share (the “Revised TOB”), which Elliott believes very significantly undervalues Toyota Industries. Elliott’s analysis showed the Company’s intrinsic net asset value to be more than ¥26,000 per share as of January 16, 2026 – almost… Continue reading Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation
@VW Group: Porsche opens new Studio in the heart of Istanbul011253
16/12/2025 The new Porsche Studio Istanbul showcases the new Cayenne Electric for the first time in Turkey. Porsche AG is unveiling one of its most comprehensive applications of Porsche’s global Studio concept in the heart of Istanbul, Etiler. A collaboration between Porsche Central and Eastern Europe (PCEE) and Doğuş Otomotiv (Porsche Türkiye), Porsche Studio Istanbul… Continue reading @VW Group: Porsche opens new Studio in the heart of Istanbul011253
German FAZ: There is no such thing as a gentle conversion010454
From the rolling hills of Tuscany, some of the difficulties in faraway Germany may seem a little less sharp. But there are tasks that have to be completed, and Wolfgang Reitzle doesn’t want to let anything slide in the last few meters of his professional life. The 76-year-old captain of industry has created a retirement… Continue reading German FAZ: There is no such thing as a gentle conversion010454
Class Action Announcement BBWI: A Securities Fraud Class Action Lawsuit Was Filed Against Bath & Body Works, Inc. (BBWI)
Were you affected by investment losses in BBWI securities between June 4, 2024, and November 19, 2025? Affected Investor Losses Summary Bath & Body Works, Inc. securities fraud class action filed Purchasers or acquirers of Bath & Body Works, Inc. (NYSE: BBWI) securities Seeking recovery of investment losses for material misstatements and/or omissions (as alleged)… Continue reading Class Action Announcement BBWI: A Securities Fraud Class Action Lawsuit Was Filed Against Bath & Body Works, Inc. (BBWI)
Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, Jan. 18, 2026 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws… Continue reading Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
WLTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront
Shares of Wealthfront Corporation declined sharply following the company’s first post-IPO earnings release, pressured by disappointing asset flow figures and emerging investor concerns about strategic exposures underpinning its mortgage business. The stock sell-off came as Wealthfront reported softer net inflows in recent months, signaling a slowdown in client acquisitions and cash management balances relative to… Continue reading WLTH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront
India to grow at a healthy 7% in 2026-27 despite global uncertainties: CareEdge
For 2026-27, CareEdge projected real GDP growth at 7 per cent, with nominal GDP growth estimated at 10.1 per cent. India’s macroeconomic outlook remains constructive heading into 2026-27. Even with external uncertainties lingering, the Indian economy is expected to record healthy growth of seven per cent in the upcoming financial year 2026-27, CareEdge Ratings has… Continue reading India to grow at a healthy 7% in 2026-27 despite global uncertainties: CareEdge
Cregis Set to Showcase Enterprise Digital Finance Solutions at iFX EXPO Dubai 2026
DUBAI, UAE, Jan. 18, 2026 /PRNewswire/ — As stablecoins, cross-border payments, and enterprise digital asset management accelerate adoption worldwide, digital finance infrastructure is entering a pivotal stage. Enterprise blockchain infrastructure provider Cregis has announced its participation at iFX EXPO Dubai 2026, taking place February 10–12. During the event, Cregis will explore the opportunities and challenges of… Continue reading Cregis Set to Showcase Enterprise Digital Finance Solutions at iFX EXPO Dubai 2026